haloperidol has been researched along with buspirone in 85 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (22.35) | 18.7374 |
| 1990's | 34 (40.00) | 18.2507 |
| 2000's | 17 (20.00) | 29.6817 |
| 2010's | 15 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldy, WJ; Barrett, DL; DiStefano, DL; Elgin, RJ; Fedde, CL; Kesslick, JM; Kukla, MJ; Martin, GE; Mathiasen, JR; Scott, MK | 1 |
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| New, JS; Riblet, LA; Taylor, DP; Temple, DL; Yevich, JP | 1 |
| Baxter, EW; Bennett, DJ; Blum, PS; Boyd, RE; Codd, EE; Kukla, MJ; Malloy, E; Maryanoff, BE; Maryanoff, CA; Scott, MK | 1 |
| Berardi, F; Colabufo, NA; Fiorentini, F; Ghiglieri, A; Govoni, S; Leopoldo, M; Olgiati, V; Perrone, R; Tortorella, V | 1 |
| Baldessarini, RJ; Booth, RG; Charifson, PS; Kula, NS; McPhail, AT; Myers, AM; Owens, CE; Wyrick, SD | 1 |
| Amlaiky, N; Hen, R; Plassat, JL | 1 |
| Arrang, JM; Diaz, J; Leurs, R; Ruat, M; Schwartz, JC; Tardivel-Lacombe, J; Traiffort, E | 1 |
| Berardi, F; Caccia, C; Fornaretto, MG; Leopoldo, M; McArthur, RA; Perrone, R; Tortorella, V | 1 |
| Berardi, F; Caccia, C; Colabufo, NA; Fornaretto, MG; Leopoldo, M; McArthur, RA; Perrone, R; Tortorella, V | 1 |
| Dokhan, R; el Ahmad, Y; Laurent, E; Maillet, P; Ollivier, R; Talab, A; Teste, JF; Tran, G | 1 |
| Audinot, V; Chaput, C; Conte, C; Gavaudan, S; Millan, MJ; Newman-Tancredi, A; Touzard, M; Verrièle, L | 1 |
| Berardi, F; Colabufo, NA; Lacivita, E; Leonardi, A; Leopoldo, M; Perrone, R; Poggesi, E; Testa, R; Tortorella, V | 1 |
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
| Claxton, CR; Curran, RE; Harradine, PJ; Hutchison, L; Littlewood, P; Martin, IJ | 1 |
| Sen, S; Sinha, N | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Bączek, T; Belka, M; Bojarski, A; Herold, F; Kleps, J; Kozioł, AE; Król, M; Nowak, G; Podsadni, P; Siwek, A; Ślifirski, G; Stachowicz, K; Szewczyk, B; Turło, J | 1 |
| Sanger, DJ | 1 |
| Rigdon, GC; Weatherspoon, JK | 1 |
| Porter, JH; Wiley, JL | 1 |
| deCosta, BR; Hardwick, WC; McMillan, DE; Rice, KC | 1 |
| Futuro-Neto, HA; Pires, JG; Silva, SR | 2 |
| Coop, CF; McNaughton, N | 1 |
| Hicks, PB; Young, KA; Zavodny, R | 1 |
| Hales, RE; Silver, JM; Yudofsky, SC | 1 |
| Berridge, KC; Treit, D | 1 |
| Amico, ET; Brotman, AW; Goff, DC; McCormick, S; Midha, KK; Waites, M | 1 |
| Davies, M; Fletcher, PJ | 1 |
| Kalkman, HO; Soar, J | 1 |
| Barrett, JE; Harrod, C; Hoffmann, SM; Lei, Z; Mansbach, RS; Nader, MA; Witkin, JM | 1 |
| Gerber, R; Gerhardt, SC; Liebman, JM | 1 |
| McMillen, BA | 1 |
| Barrett, JE; Witkin, JM | 1 |
| Pich, EM; Samanin, R | 1 |
| Blair, D; Matthews, RT; McMillen, BA; Sallis, R | 1 |
| Salama, AI; Saller, CF | 1 |
| Howard, JL; Pollard, GT | 1 |
| Henke, PG; Ray, A; Sullivan, RM | 1 |
| Le Moal, M; Louilot, A; Simon, H | 1 |
| Barrett, JE; Mansbach, RS | 1 |
| Consolo, S; Fusi, R; Garattini, S; Kolasa, K; Ladinsky, H | 1 |
| Caccia, S; Garattini, S; Mennini, T | 1 |
| Fleming, R; Meltzer, HY | 1 |
| McDonald, CC; McMillen, BA | 1 |
| Etienne, P; Lal, S; Nair, NP; Wood, PL | 1 |
| Achilli, G; Algeri, S; Cimino, M; Garattini, S; Perego, C; Ponzio, F; Vantini, G | 1 |
| Battistin, L; Dam, M; Freo, U; Furey-Kurkjian, M; Merico, A; Pietrini, P; Pizzolato, G; Ruggero, S | 1 |
| Cole, JC; Rodgers, RJ | 1 |
| Lum-Ragan, JT; Piercey, MF; Smith, MW | 1 |
| Conceição, IM; Frussa-Filho, R | 1 |
| Futuro-Neto, HA; Pires, JG; Ramage, AG; Silva, SR | 1 |
| Rapoza, D | 1 |
| Sunderland, T | 1 |
| Chang, TP; Chang, WH; Chen, JS; Chien, CP; Huang, HF; Jann, MW; Juang, DJ; Lam, YW; Lin, SK; Wei, FC | 1 |
| Muro, MA; Palacios, G; Paz Marín, A | 1 |
| Frussa-Filho, R; Queiroz, CM | 1 |
| Christ, G; Kaynan, A; Maayani, S; Melman, A; Rehman, J; Valcic, M | 1 |
| Cassella, JV; Coverdale, S; Hoffman, DC; Kehne, JH; McCloskey, TC | 1 |
| Costall, B; Neill, JC; Wilson, AW | 1 |
| Alcântara, FB; Bibancos, T; Frussa-Filho, R; Queiroz, CM; Yagüe, AM | 1 |
| Haleem, DJ; Haleem, MA; Shireen, E | 1 |
| Barsvári, B; Haller, J; Levay, G; Leveleki, C; Mikics, E; Soproni, K; Sziray, N | 1 |
| Haleem, DJ; Haleem, MA; Samad, N | 2 |
| Klein, S; Nicolas, LB; Prinssen, EP | 1 |
| Breese, GR; Knapp, DJ; Overstreet, DH | 1 |
| Balsara, JJ; Gaikwad, RV; Gaonkar, RK; Gursale, SC; Jadhav, SA; Thorat, VM | 1 |
| Frisch, J; Hiemke, C; Holthoewer, D; Kirschbaum, KM; Schmitt, U | 1 |
| Hillhouse, TM; LaCrosse, AL; Prus, AJ | 1 |
| Ahmadi, SA; Haddadi, R; Sabahi, M | 1 |
3 review(s) available for haloperidol and buspirone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacologic management of aggression in the elderly.
Topics: Aged; Aggression; Antipsychotic Agents; Benzodiazepines; Buspirone; Dementia; Haloperidol; Humans; Lorazepam; Neurocognitive Disorders | 1990 |
Treatment of the elderly suffering from psychosis and dementia.
Topics: Age Factors; Aged; Alzheimer Disease; Antipsychotic Agents; Buspirone; Clinical Trials as Topic; Dementia; Drug Administration Schedule; Haloperidol; Humans; Loxapine; Nursing Homes; Psychotic Disorders | 1996 |
2 trial(s) available for haloperidol and buspirone
| Article | Year |
|---|---|
An open trial of buspirone added to neuroleptics in schizophrenic patients.
Topics: Adult; Buspirone; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1991 |
Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and man.
Topics: Adult; Animals; Anti-Anxiety Agents; Buspirone; Diazepam; Dopamine Antagonists; Growth Hormone; Haloperidol; Humans; Hypothalamus; Male; Prolactin; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Secretory Rate; Stimulation, Chemical | 1982 |
80 other study(ies) available for haloperidol and buspirone
| Article | Year |
|---|---|
Pyrrole mannich bases as potential antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Male; Mannich Bases; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin; Structure-Activity Relationship | 1992 |
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Buspirone analogues. 1. Structure-activity relationships in a series of N-aryl- and heteroarylpiperazine derivatives.
Topics: Animals; Anti-Anxiety Agents; Binding, Competitive; Buspirone; Corpus Striatum; Kinetics; Male; Models, Molecular; Molecular Conformation; Piperazines; Pyrimidines; Rats; Receptors, Dopamine; Spiperone; Structure-Activity Relationship | 1983 |
Piperazinylalkyl heterocycles as potential antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Azepines; Azocines; Cell Membrane; Cerebral Cortex; Conditioning, Psychological; Drug Stability; Furans; Hydrogen-Ion Concentration; Male; Molecular Structure; Piperazines; Piperidones; Rats; Rats, Inbred F344; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin; Structure-Activity Relationship | 1995 |
High affinity and selectivity on 5-HT1A receptor of 1-aryl-4-[1-tetralin)alkyl]piperazines. 2.
Topics: Animals; Chemical Phenomena; Chemistry, Physical; Guinea Pigs; Isomerism; Kinetics; Male; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1995 |
Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor.
Topics: Animals; Ligands; Models, Molecular; Molecular Conformation; Receptors, sigma; Rodentia; Structure-Activity Relationship; Tetrahydronaphthalenes | 1994 |
Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase.
Topics: Adenylyl Cyclases; Amino Acid Sequence; Animals; Base Sequence; Brain; Cloning, Molecular; Cyclic AMP; DNA; Drosophila; Enzyme Activation; Humans; Intestinal Mucosa; Mice; Molecular Sequence Data; Myocardium; Receptors, Serotonin; Sequence Homology, Amino Acid; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |
Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.
Topics: Amino Acid Sequence; Animals; Base Sequence; Blotting, Northern; Brain; CHO Cells; Cricetinae; Cyclic AMP; DNA; Genomic Library; Kinetics; Lysergic Acid Diethylamide; Mianserin; Molecular Sequence Data; Multigene Family; Oligodeoxyribonucleotides; Organ Specificity; Rats; Receptors, Serotonin; Restriction Mapping; Serotonin; Serotonin Receptor Agonists; Transfection | 1993 |
1-aryl-4-[(1-tetralinyl)alkyl]piperazines: alkylamido and alkylamino derivatives. Synthesis, 5-HT1A receptor affinity, and selectivity. 3.
Topics: Animals; Buspirone; Mass Spectrometry; Molecular Structure; Piperazines; Protein Binding; Rats; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Receptor Agonists | 1996 |
Structure-activity relationship studies on the 5-HT(1A) receptor affinity of 1-phenyl-4-[omega-(alpha- or beta-tetralinyl)alkyl]piperazines. 4.
Topics: Magnetic Resonance Spectroscopy; Piperazines; Radioligand Assay; Receptors, Serotonin; Structure-Activity Relationship | 1996 |
New benzocycloalkylpiperazines, potent and selective 5-HT1A receptor ligands.
Topics: Adenylyl Cyclases; Animals; Behavior, Animal; Binding, Competitive; Colforsin; Cyclic AMP; Electrophysiology; Enzyme Activation; Kinetics; Magnetic Resonance Spectroscopy; Molecular Conformation; Molecular Structure; Piperazines; Protein Binding; Rats; Rats, Wistar; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Stereoisomerism; Structure-Activity Relationship | 1997 |
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
Topics: Animals; Antipsychotic Agents; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Agents; Sulfur Radioisotopes | 1998 |
trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
Topics: Animals; Brain; Ethylamines; Guanosine 5'-O-(3-Thiotriphosphate); HeLa Cells; Humans; In Vitro Techniques; Ligands; Molecular Conformation; Piperazines; Pyridines; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Stereoisomerism; Structure-Activity Relationship; Transfection | 2001 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding.
Topics: Animals; Blood Proteins; Buffers; Carbon Dioxide; Chemical Phenomena; Dialysis; Dogs; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Macaca fascicularis; Mice; Osmolar Concentration; Pharmaceutical Preparations; Protein Binding; Rats; Reproducibility of Results | 2011 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Synthesis of new 5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT
Topics: Animals; Cells, Cultured; Crystallography, X-Ray; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Ligands; Male; Mice; Models, Molecular; Molecular Structure; Pyrimidines; Rats; Receptor, Serotonin, 5-HT1A; RNA-Binding Proteins; Structure-Activity Relationship; Tryptamines | 2019 |
Increased rates of punished responding produced by buspirone-like compounds in rats.
Topics: Animals; Anti-Anxiety Agents; Buspirone; Chlordiazepoxide; Conditioning, Operant; Dioxins; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Injections, Intravenous; Male; Punishment; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Spiro Compounds | 1992 |
5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acoustic Stimulation; Animals; Buspirone; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Male; Methoxydimethyltryptamines; Pyrimidines; Rats; Rats, Wistar; Receptors, Serotonin; Reflex, Startle; Schizophrenia; Serotonin Receptor Agonists | 1992 |
Serotonergic drugs do not substitute for clozapine in clozapine-trained rats in a two-lever drug discrimination procedure.
Topics: Animals; Buspirone; Clozapine; Discrimination, Psychological; Dose-Response Relationship, Drug; Generalization, Psychological; Haloperidol; Male; Rats; Rats, Sprague-Dawley; Ritanserin; Serotonin Antagonists; Serotonin Receptor Agonists; Tropanes | 1992 |
Effects of drugs that bind to PCP and sigma receptors on punished responding.
Topics: Animals; Buspirone; Dizocilpine Maleate; Haloperidol; Learning; Male; Pentobarbital; Phenazocine; Phencyclidine; Punishment; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Phencyclidine; Receptors, sigma | 1991 |
Dorsal raphe nucleus lesions have no effect on neuroleptic-induced catalepsy and on the anticataleptic activity of buspirone.
Topics: Animals; Buspirone; Catalepsy; Haloperidol; Male; Raphe Nuclei; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1991 |
Buspirone affects hippocampal rhythmical slow activity through serotonin1A rather than dopamine D2 receptors.
Topics: Animals; Buspirone; Chlordiazepoxide; Drug Interactions; Electrophysiology; Female; Haloperidol; Hippocampus; Male; Periodicity; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin | 1991 |
Subchronic buspirone, mesulergine, and ICS 205-930 lack effects on D1 and D2 dopamine binding in the rat striatum during chronic haloperidol treatment.
Topics: Animals; Apomorphine; Buspirone; Corpus Striatum; Ergolines; Haloperidol; In Vitro Techniques; Indoles; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Serotonin Antagonists; Stereotyped Behavior; Tropisetron; Up-Regulation | 1991 |
A comparison of benzodiazepine, serotonin, and dopamine agents in the taste-reactivity paradigm.
Topics: Amphetamine; Animals; Apomorphine; Benzodiazepines; Buspirone; Chlordiazepoxide; Diazepam; Dopamine Agents; Feeding Behavior; Haloperidol; Male; Pyrimidines; Quinine; Rats; Rats, Inbred Strains; Serotonin; Sucrose; Taste | 1990 |
Inhibition of chlorpromazine-induced catalepsy by the 5-HT-1A ligands pindolol and buspirone in mice.
Topics: Animals; Buspirone; Catalepsy; Chlorpromazine; Clomipramine; Female; Haloperidol; Male; Mice; Pindolol; Receptors, Serotonin | 1990 |
The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Dopamine; Dose-Response Relationship, Drug; Eating; Fenclonine; Haloperidol; Male; Pyrimidines; Raphe Nuclei; Rats; Rats, Inbred Strains; Serotonin; Tetrahydronaphthalenes | 1990 |
Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Dioxanes; Haloperidol; Male; Motor Activity; Pindolol; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Spiro Compounds; Tetrahydronaphthalenes | 1990 |
Behavioral studies with anxiolytic drugs. V. Behavioral and in vivo neurochemical analyses in pigeons of drugs that increase punished responding.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Buspirone; Chlordiazepoxide; Clozapine; Columbidae; Conditioning, Operant; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Punishment; Pyrimidines | 1988 |
Effects of 5-HT1A agonists and 5-HT2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys: no evidence for reciprocal 5-HT-dopamine interaction.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Apomorphine; Avoidance Learning; Buspirone; Dopamine; Haloperidol; Male; Movement Disorders; Pyrimidinones; Saimiri; Serotonin; Serotonin Antagonists; Tetrahydronaphthalenes | 1989 |
Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Body Weight; Buspirone; Dopamine; Female; Haloperidol; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Synaptic Transmission; Time Factors; Trifluoperazine; Tyrosine 3-Monooxygenase | 1985 |
Interaction of buspirone and dopaminergic agents on punished behavior of pigeons.
Topics: Animals; Anti-Anxiety Agents; Apomorphine; Buspirone; Chlordiazepoxide; Columbidae; Conditioning, Operant; Dose-Response Relationship, Drug; Electroshock; Haloperidol; Male; Punishment; Pyrimidines; Receptors, Dopamine | 1986 |
Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine.
Topics: Animals; Anti-Anxiety Agents; Apomorphine; Behavior, Animal; Buspirone; Drug Interactions; Exploratory Behavior; Haloperidol; Male; Motor Activity; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride | 1986 |
Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Brain; Buspirone; Dopamine; Female; Haloperidol; Neurons; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Substantia Nigra; Tyrosine 3-Monooxygenase | 1986 |
3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Buspirone; Carbazoles; Chlorpromazine; Clozapine; Corpus Striatum; Dopamine; Dopamine Antagonists; Fluphenazine; Haloperidol; Male; Molindone; Pargyline; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Regression Analysis | 1986 |
Similar effects of antidepressant and non-antidepressant drugs on behavior under an interresponse-time greater than 72-s schedule.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Buspirone; Chlorpromazine; Haloperidol; Imipramine; Male; Pyrimidines; Rats; Rats, Inbred Strains; Reinforcement, Psychology; Time Factors | 1986 |
The effects of buspirone, a selective anxiolytic, on stress ulcer formation in rats.
Topics: Animals; Apomorphine; Buspirone; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Injections, Intraperitoneal; Male; Rats; Rats, Inbred Strains; Stomach; Stomach Ulcer; Stress, Physiological | 1988 |
Presynaptic control of dopamine metabolism in the nucleus accumbens. Lack of effect of buspirone as demonstrated using in vivo voltammetry.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Buspirone; Corpus Striatum; Dopamine; Electrochemistry; Haloperidol; Male; Neural Conduction; Nucleus Accumbens; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Septal Nuclei; Synapses; Tetrodotoxin | 1987 |
Discriminative stimulus properties of buspirone in the pigeon.
Topics: Animals; Apomorphine; Buspirone; Clozapine; Columbidae; Discrimination Learning; Haloperidol; Methysergide; Midazolam; Pyrimidines; Serotonin | 1987 |
Neurochemical effects of buspirone, a novel psychotropic drug, on the central cholinergic system.
Topics: Acetylcholine; Animals; Anti-Anxiety Agents; Apomorphine; Brain Chemistry; Buspirone; Clozapine; Corpus Striatum; Female; Haloperidol; Male; Parasympathetic Nervous System; Postural Balance; Pyrimidines; Rats; Time Factors | 1982 |
Notes on buspirone's mechanisms of action.
Topics: Acetylcholine; Animals; Anti-Anxiety Agents; Behavior, Animal; Brain Chemistry; Buspirone; Catalepsy; Chemical Phenomena; Chemistry; Clozapine; Corpus Striatum; Dopamine; Haloperidol; Humans; Pyrimidines; Receptors, Cell Surface; Receptors, GABA-A; Stereotyped Behavior | 1982 |
Selective effects of buspirone and molindone on dopamine metabolism and function in the striatum and frontal cortex of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Buspirone; Catalepsy; Cerebral Cortex; Corpus Striatum; Dopamine; Female; Haloperidol; Humans; Indoles; Molindone; Pyrimidines; Rats; Rats, Inbred Strains; Time Factors | 1983 |
Buspirone: a potential atypical neuroleptic.
Topics: Animals; Antipsychotic Agents; Buspirone; Clozapine; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Male; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substantia Nigra; Sulpiride; Time Factors | 1983 |
Dopaminergic effects of buspirone, a novel anxiolytic agent.
Topics: Animals; Buspirone; Clozapine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Haloperidol; In Vitro Techniques; Pyrimidines; Rats; Receptors, Dopamine | 1983 |
Dose-dependent effects of buspirone on behavior and cerebral glucose metabolism in rats.
Topics: Animals; Behavior, Animal; Brain; Buspirone; Deoxyglucose; Dopamine Agonists; Dose-Response Relationship, Drug; Glucose; Haloperidol; Male; Monitoring, Physiologic; Rats; Rats, Inbred F344; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Receptor Agonists; Tetrahydronaphthalenes | 1995 |
Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.
Topics: Animals; Anxiety; Behavior, Animal; Buspirone; Exploratory Behavior; Haloperidol; Male; Mice; Mice, Inbred DBA; Posture; Risk-Taking; Time Factors | 1994 |
Excitation of noradrenergic cell firing by 5-hydroxytryptamine1A agonists correlates with dopamine antagonist properties.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Dopamine; Dopamine Antagonists; Haloperidol; Locus Coeruleus; Male; Neurons; Norepinephrine; Pyrimidines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Receptor Agonists; Substantia Nigra | 1994 |
Effects of a single administration of buspirone on catalepsy, yawning and stereotypy in rats.
Topics: Analysis of Variance; Animals; Apomorphine; Buspirone; Catalepsy; Haloperidol; Male; Rats; Rats, Wistar; Stereotyped Behavior; Yawning | 1993 |
Effects of the 5-HT receptor antagonists cyanopindolol, ICI 169,369, cisapride and granisetron on neuroleptic-induced catalepsy in mice.
Topics: Animals; Buspirone; Catalepsy; Cisapride; Female; Granisetron; Haloperidol; Male; Mice; Pindolol; Piperidines; Quinolines; Serotonin Antagonists; Time Factors | 1993 |
Buspirone fails to affect the discriminative stimulus effects of cocaine.
Topics: Animals; Buspirone; Cocaine; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Haloperidol; Injections, Intraperitoneal; Male; Rats; Rats, Sprague-Dawley | 1993 |
Lack of pharmacokinetic interaction between buspirone and haloperidol in patients with schizophrenia.
Topics: Adult; Analysis of Variance; Anti-Anxiety Agents; Antipsychotic Agents; Buspirone; Chromatography, High Pressure Liquid; Drug Interactions; Drug Therapy, Combination; Haloperidol; Humans; Middle Aged; Schizophrenia | 1996 |
Differential effects of haloperidol and two anxiolytic drugs, buspirone and lesopitron, on c-Fos expression in the rat striatum and nucleus accumbens.
Topics: Animals; Buspirone; Corpus Striatum; Haloperidol; Male; Nucleus Accumbens; Piperazines; Proto-Oncogene Proteins c-fos; Pyrimidines; Rats; Rats, Wistar; Serotonin Receptor Agonists | 1996 |
Effects of buspirone on dopaminergic supersensitivity.
Topics: Animals; Anti-Anxiety Agents; Apomorphine; Behavior, Animal; Buspirone; Dopamine; Dopamine Antagonists; Drug Interactions; Haloperidol; Male; Motor Activity; Rats; Rats, Wistar; Stereotyped Behavior | 1997 |
Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain Chemistry; Buspirone; Copulation; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Penile Erection; Penis; Piperazines; Pyrimidines; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reflex; Serotonin; Serotonin Receptor Agonists; Spiperone | 1999 |
Effects of the CRF(1) receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Behavior, Animal; Buspirone; Clozapine; Desipramine; Diazepam; Dose-Response Relationship, Drug; Female; Haloperidol; Injections, Intraperitoneal; Male; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Social Isolation; Stress, Psychological; Vocalization, Animal; Zimeldine | 2000 |
Manipulation of operant responding for an ethanol-paired conditioned stimulus in the rat by pharmacological alteration of the serotonergic system.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Alcohol Drinking; Amphetamines; Animals; Buspirone; Conditioning, Operant; Dopamine Antagonists; Ethanol; Female; Fenfluramine; Haloperidol; Piperazines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Receptor Agonists | 2000 |
Acute buspirone abolishes the expression of behavioral dopaminergic supersensitivity in mice.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Buspirone; Dopamine; Dopamine Antagonists; Drug Hypersensitivity; Drug Interactions; Dyskinesia, Drug-Induced; Haloperidol; Locomotion; Male; Mice; Stereotyped Behavior | 2002 |
Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Brain Chemistry; Buspirone; Catalepsy; Chromatography, High Pressure Liquid; Corpus Striatum; Drug Interactions; Electrochemistry; Haloperidol; Male; Random Allocation; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Serotonin | 2004 |
Pharmacological evaluation of the stress-induced social avoidance model of anxiety.
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Buspirone; Chlordiazepoxide; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Haloperidol; Male; Models, Neurological; Motor Activity; Phobic Disorders; Piperazines; Rats; Rats, Wistar; Reproducibility of Results; Serotonin Receptor Agonists; Stress, Psychological | 2006 |
Reversal of haloperidol-induced extrapyramidal symptoms by buspirone: a time-related study.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Ataxia; Buspirone; Catalepsy; Dyskinesia, Drug-Induced; Haloperidol; Male; Motor Activity; Rats; Rats, Wistar; Time Factors | 2007 |
Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Buspirone; Chromatography, High Pressure Liquid; Dendrites; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Electrochemistry; Exploratory Behavior; Haloperidol; Hydroxyindoleacetic Acid; Male; Motor Activity; Rats; Rats, Wistar; Serotonin; Serotonin Receptor Agonists; Serotonin Syndrome; Stereotyped Behavior | 2007 |
Defensive-like behaviors induced by ultrasound: further pharmacological characterization in Lister-hooded rats.
Topics: Amines; Analgesics, Opioid; Animals; Anti-Anxiety Agents; Bridged Bicyclo Compounds; Buspirone; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Diazepam; Dose-Response Relationship, Drug; Escape Reaction; Fear; Freezing Reaction, Cataleptic; Gabapentin; gamma-Aminobutyric Acid; Haloperidol; Imidazoles; Male; Morphine; Motor Activity; Nociceptin Receptor; Pregabalin; Pyridines; Rats; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, Opioid; Spiro Compounds; Thiazoles; Ultrasonics | 2007 |
Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats.
Topics: Alcohol Drinking; Aminopyridines; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzodiazepines; Buspirone; Dopamine Antagonists; Ethanol; Flumazenil; GABA Modulators; Haloperidol; Indoles; Naloxone; Narcotic Antagonists; Olanzapine; Rats; Rats, Inbred Strains; Restraint, Physical; Serotonin Receptor Agonists; Stress, Physiological; Substance Withdrawal Syndrome | 2007 |
Dose-dependent response of central dopaminergic systems to buspirone in mice.
Topics: Animals; Anti-Anxiety Agents; Buspirone; Catalepsy; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Mice; Serotonin Receptor Agonists; Stereotyped Behavior; Tryptophan | 2008 |
Pharmacodynamic effects of aripiprazole and ziprasidone with respect to p-glycoprotein substrate properties.
Topics: Animals; Antipsychotic Agents; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buspirone; Haloperidol; Ketanserin; Male; Mice; Mice, Knockout; Motor Activity; Piperazines; Quinolones; Rotarod Performance Test; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles | 2013 |
Acute, but not repeated, administration of the neurotensin NTS1 receptor agonist PD149163 decreases conditioned footshock-induced ultrasonic vocalizations in rats.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Buspirone; Catalepsy; Conditioning, Psychological; Drug Tolerance; Electroshock; Fear; Haloperidol; Male; Neurotensin; Rats; Rats, Wistar; Receptors, Neurotensin; Vocalization, Animal | 2014 |
The effect of acute and repeated administration of buspirone, 8-OHDPAT and fluoxetine on haloperidol-induced extrapyramidal symptoms.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Catalepsy; Fluoxetine; Haloperidol; Male; Pyramidal Cells; Rats; Rats, Wistar | 2019 |